MONFIT:基于时间序列数据的多omics因子集成对帕金森病的研究有所帮助
Katarina Mihajlović1, Noël Malod-Dognin1, Corrado Ameli2
1Barcelona Supercomputing Center (BSC), 08034 Barcelona, Spain.
NAR molecular medicine
|November 19, 2025
概括
我们开发了MONFIT,这是一个用于分析多omics数据的新管道,以了解帕金森病 (PD) 的进展. 这种方法通过整合各种分子数据来识别新的PD相关基因和潜在的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 基因组学就是基因组学.
- 系统生物学 系统生物学
背景情况:
- 帕金森病 (PD) 是一种复杂的神经退行性疾病,其机制尚不清楚,阻碍了有效的治疗开发.
- 纵向的多omics数据为阐明PD病因和进展提供了潜力,但需要先进的分析工具.
- 现有的数据分析框架很难整合异质的时间序列omics数据,以获得整体的疾病观点.
研究的目的:
- 介绍MONFIT,一种用于整合和分析纵向多学科数据的新型计算管道.
- 为了识别与帕金森病相关的新型基因和分子通路.
- 通过药物重新定位来探索帕金森病的新治疗干预机会.
主要方法:
- 开发MONFIT,使用非负矩阵三因子化的整体分析管道.
- 时间序列单细胞RNA测序,批量蛋白质组学和代谢组学数据的整合.
- 将分子网络的先验知识纳入分析框架.
主要成果:
- MONFIT应用于患者衍生的诱导多能干细胞,使其分化为多巴胺基神经元.
- 鉴定与帕金森病病理学相关的新基因.
- 强调关键的分子通路与帕金森病的进展有关.
结论:
- MONFIT为分析神经退行性疾病中复杂的纵向多omics数据提供了一个强大的框架.
- 这项研究突出了对帕金森病病原体的新型分子见解.
- 这些发现表明,在帕金森病中,治疗干预和药物重定向的潜在途径.
相关概念视频
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Parkinson's Disease: Treatment
953
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
953
Drug Concentration Versus Time Correlation
1.9K
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
1.9K


